These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 23169419)

  • 41. Epstein-Barr virus-associated T-cell lymphoproliferative disorder affecting skin and lung in an elderly patient.
    Hoshino T; Tatsuno K; Shimauchi T; Okada S; Ito T; Ono T; Ohshima K; Tokura Y
    J Dermatol; 2014 Sep; 41(9):837-40. PubMed ID: 25109697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
    Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
    Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
    Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease.
    Ishihara S; Yabuta R; Tokura Y; Ohshima K; Tagawa S
    Int J Hematol; 2000 Aug; 72(2):223-8. PubMed ID: 11039673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013.
    Hamada T; Nakamura S; Ko YH; Yoshino T; Ohshima K; Matsuzawa T; Miura K; Takahashi T; Nomura H; Hoshino T; Suzuki D; Shimada S; Iwatsuki K
    J Dermatol; 2014 Jan; 41(1):40-2. PubMed ID: 24438143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
    Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions.
    Demachi A; Nagata H; Morio T; Oyoshi MK; Zhang Y; Tabata N; Kimura N; Shimizu N; Yamamoto K
    Microbiol Immunol; 2003; 47(7):543-52. PubMed ID: 12953848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
    Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous EBV-related lymphoproliferative disorders.
    Gru AA; Jaffe ES
    Semin Diagn Pathol; 2017 Jan; 34(1):60-75. PubMed ID: 27988064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases.
    Rodríguez-Pinilla SM; Barrionuevo C; García J; de los Ángeles M; Pajares R; Casavilca S; Montes J; Martínez A; Montes-Moreno S; Sánchez L; Piris MÁ
    Histopathology; 2011 Dec; 59(6):1183-93. PubMed ID: 22175898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current research on chronic active Epstein-Barr virus infection in Japan.
    Fujiwara S; Kimura H; Imadome K; Arai A; Kodama E; Morio T; Shimizu N; Wakiguchi H
    Pediatr Int; 2014 Apr; 56(2):159-66. PubMed ID: 24528553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disorders Manifested as Gastrointestinal Perforations and Skin Lesions: A Case Report.
    Xiao HJ; Li J; Song HM; Li ZH; Dong M; Zhou XG
    Medicine (Baltimore); 2016 Feb; 95(5):e2676. PubMed ID: 26844502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
    Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.
    Eminger LA; Hall LD; Hesterman KS; Heymann WR
    J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroa vacciniforme lymphoproliferative disorder: a retrospective study of 42 paediatric cases.
    Zhang Y; Liu Y; Xu J; Liang Y; Xu Z
    Eur J Dermatol; 2024 Apr; 34(2):144-149. PubMed ID: 38907544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.
    Cohen JI; Manoli I; Dowdell K; Krogmann TA; Tamura D; Radecki P; Bu W; Turk SP; Liepshutz K; Hornung RL; Fassihi H; Sarkany RP; Bonnycastle LL; Chines PS; Swift AJ; Myers TG; Levoska MA; DiGiovanna JJ; Collins FS; Kraemer KH; Pittaluga S; Jaffe ES
    Blood; 2019 Jun; 133(26):2753-2764. PubMed ID: 31064750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.